info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Middle-East and Africa clinical trial imaging Market is expected to reach US$ 115.6 million by 2022

Pune, India, April, 2017 /MRFR Press Release/- Market research future has a half cooked research report on Middle-East and Africa Clinical trial imaging Market. The market for Middle-East and Africa Clinical trial imaging market is growing continuously and expected to grow at a CAGR of 6.1% from 2015 to 2022


Market Highlights


The Middle-East and Africa Clinical trial imaging Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Clinical trial is major process in drug development process. Drug development process is expensive and need huge funding. Imaging perform different functions in clinical trials like detection, characterization, and monitoring or assessment. Pharmaceutical and biotechnology companies investing in R&D to develop new drugs which further observed and make available to the public. Imaging also plays important role to minimize the cost of clinical trials. Imaging is a natural fit for early phase trials, since they are more dynamic and involve more scientific work than later-phase trials. Imaging biomarkers to increase the probability of success in clinical trials and to evaluate efficacy more rapidly. Increasing number of non-communicable diseases, improved healthcare infrastructure, and government initiatives are leading the growth for clinical trial imaging market in Middle East and Africa. However, there are some factors affecting the growth for clinical trial imaging market in Middle East and Africa such as inaccurate data collection, improper data sharing, expensive drug development process, limited access to the advance imaging technology, delays in trial, strict government regulations etc.


Middle-East and Africa Clinical trial imaging Market was estimated of US$ 76.1 million in 2015 and expected to reach US$ 115.6 million by 2022 at a CAGR of 6.1%.


Access Report Details @ https://www.marketresearchfuture.com/reports/clinical-trial-imaging-market-2580


Middle-East and Africa Clinical trial imaging Market Players:


There are plenty of large and small market players which operate in this market all over the Middle East and Africa region, such as Bioclinica, Inc. (US), Cardiovascular Imaging Technologies, LLC (US), Parexel International Corporation (US), Biomedical Systems Corporation (US), Icon PLC (Republic of Ireland), Intrinsic Imaging LLC (US), Biotelemetry, Inc. (US), Intrinsic Imaging LLC (US), Parexel International Corporation (US).


Regional Analysis

:


Considering the Middle-East and Africa Clinical trial imaging Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Clinical trial imaging market. Moreover Saudi Arabia market is also growing and second largest market for Clinical trial imaging. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Clinical trial imaging market during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.


Segmentation:


Middle East and Africa clinical trial imaging market has been segmented on the basis of products which comprises of Services, Software, and others. On the basis of modality, the market is segmented into X-Ray, Ultrasound, CT, PET, MRI, Echocardiography, and others. On the basis of end user, the market segmented into pharmaceutical companies, biotech companies, research centers, hospitals and others.


About Market Research Future:


At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


Contact


Akash Anand,


Market Research Future


Office No. 528, Amanora Chambers


Magarpatta Road, Hadapsar,


Pune - 411028


Maharashtra, India


+1 646 845 9312


Email: akash.anand@marketresearchfuture.com

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.